SynthesisClinical oral implants research2026
Tobacco Smoking and Smoke-Free Products as Risk Factors for Dental Implants: A Systematic Review.
Synthesis in Clinical oral implants research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Failure of Wide-Diameter Dental Implants (Predominantly 5.0 mm) Show Distinct Risk Profiles-A Large Cohort Study.Clinical implant dentistry and related research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis systematic review aimed to investigate the effect of tobacco smoking and smoke-free products as risk factors for dental implants. MATERIALS AND
methodsThree databases were searched to identify studies reporting on the risk of implant failure/survival in tobacco smokers or smoke-free users as compared to non-smokers in studies with ≥ 1 year of follow-up post-implant loading. Data on biological complications and radiographic peri-implant crestal bone loss (CBL) were also collected. Meta-analyses computed the Odds Ratio (OR) of implant survival with its confidence interval by applying the DerSimonian and Laird's random effect method, with p set at < 0.01.
resultsForty-five articles reporting on 44 studies were included, 41 of which reported on the effect of cigarette smoking, with a follow-up from 1 to up to 17 years. Overall, a significantly reduced implant survival both at implant and patient level was indicated in cigarette smokers (OR = 0.40, 95% CI 0.27; 0.61, p < 0.001 and OR = 0.43, 95% CI 0.20; 0.90, p = 0.02, respectively). An increased CBL of 0.64 mm (95% CI 0.29; 0.99, p < 0.001) was also suggested in cigarette smokers, and the majority of studies reported a higher incidence of peri-implantitis. Insufficient data are available for smoke-free users.
conclusionsAlthough tobacco smoking is not considered an absolute contraindication for implant therapy, evidence indicates that it has a detrimental effect on peri-implant tissues, leading to an increased risk of implant failure and crestal bone loss. Individual behavioural counselling for smoking cessation should always be integrated in the treatment plan of patients receiving implant-supported rehabilitations.
trial registrationPROSPERO number: CRD42024628116.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.